Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02406690 · ClinicalTrials.gov registry record

Endometrial Receptivity Profile in Patients With Endometrial Proliferation Defects

A clinical trial, sponsored by Reproductive Medicine Associates of New Jersey.

Completed
Registry status
1
Enrollment target

NCT02406690 is a clinical trial that has completed, run by Reproductive Medicine Associates of New Jersey. The registered enrollment target is 1 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02406690 has completed, sponsored by Reproductive Medicine Associates of New Jersey.

COMPLETED
Registry status
1 participants
Enrollment target

Study Summary

The purpose of this study is to determine the differences that exist in RNA molecules, the biochemical process of methylation, and estrogen receptor binding in patients that have failed to produce adequate endometrium in synthetic embryo transfer cycles when compared to patients whose endometrium thickness is within normal limits.

Interventions

  • OTHER Estradiol Valerate, Progesterone in Oil, Leuprolide

Trial Details

FieldValue
Enrollment Target 1 participants
Start Date 2015-07-31
Est. Completion 2015-09-17

What the Registry Record Tells You About NCT02406690

The ClinicalTrials.gov registry entry for NCT02406690 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 1 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Reproductive Medicine Associates of New Jersey, which has 51 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 1 intervention - of which Estradiol Valerate, Progesterone in Oil, Leuprolide is the first listed.

NCT02406690 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT02406690 about?

NCT02406690 is a clinical study titled "Endometrial Receptivity Profile in Patients With Endometrial Proliferation Defects". The purpose of this study is to determine the differences that exist in RNA molecules, the biochemical process of methylation, and estrogen receptor binding in patients that have failed to produce adequate endometrium in synthetic embryo transfer cycles when compared to patients whose endometrium th...

What is the current status of trial NCT02406690?

This trial is currently completed. The enrollment target is 1 participants. The study started on 2015-07-31. Estimated completion is 2015-09-17.

What interventions are being tested in trial NCT02406690?

The interventions under investigation include: Estradiol Valerate, Progesterone in Oil, Leuprolide (OTHER).

Who is sponsoring clinical trial NCT02406690?

This trial is sponsored by Reproductive Medicine Associates of New Jersey, which has 51 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.